Today is Thursday, Dec. 5, 2019

Department of

Cancer Biology - Waltz Laboratory

Peer Reviewed Publications

2019

Babicky, Michele L; Harper, Megan M; Chakedis, Jeffery; Cazes, Alex; Mose, Evangeline S; Jaquish, Dawn V; French, Randall P; Childers, Betzaira; Alakus, Hakan; Schmid, Michael C; Foubert, Phillippe; Miyamoto, Jaclyn; Holman, Patrick J; Walterscheid, Zakkary J; Tang, Chih-Min; Varki, Nissi; Sicklick, Jason K; Messer, Karen; Varner, Judith A; Waltz, Susan E; Lowy, Andrew M 2019. MST1R kinase accelerates pancreatic cancer progression via effects on both epithelial cells and macrophages. Oncogene, ,

Ge, Chunmin; Vilfranc, Chrystelle L; Che, Lixiao; Pandita, Raj K; Hambarde, Shashank; Andreassen, Paul R; Niu, Liang; Olowokure, Olugbenga; Shah, Shimul; Waltz, Susan E; Zou, Lee; Wang, Jiang; Pandita, Tej K; Du, Chunying 2019. The BRUCE-ATR signaling axis is required for accurate DNA replication and suppression of liver cancer development. Hepatology (Baltimore, Md.), ,

2018

Brown, Nicholas E; Paluch, Andrew M; Nashu, Madison A; Komurov, Kakajan; Waltz, Susan E 2018. Tumor Cell Autonomous RON Receptor Expression Promotes Prostate Cancer Growth Under Conditions of Androgen Deprivation. Neoplasia (New York, N.Y.), 20 9, 917-929

Brown, Nicholas E; Sullivan, Camille; Waltz, Susan E 2018. Therapeutic Considerations for Ron Receptor Expression in Prostate Cancer. EMS cancer science journal, 1 1,

Modur, Vishnu; Singh, Navneet; Mohanty, Vakul; Chung, Eunah; Muhammad, Belal; Choi, Kwangmin; Chen, Xiaoting; Chetal, Kashish; Ratner, Nancy; Salomonis, Nathan; Weirauch, Matthew T; Waltz, Susan; Huang, Gang; Privette-Vinnedge, Lisa; Park, Joo-Seop; Janssen, Edith M; Komurov, Kakajan 2018. Defective transcription elongation in a subset of cancers confers immunotherapy resistance. Nature communications, 9 1, 4410

2017

Benight N.; Guan J.; Karns R.; Lower E.; Ruiz-Torres S.; Waltz S. 01-01-2017. HGFL-mediated RON signaling supports breast cancer stem cell phenotypes via activation of non-canoni Oncotarget, 8 35, 58918-58933

Andrade, Kelsi; Fornetti, Jaime; Zhao, Ling; Miller, Scott C; Randall, R Lor; Anderson, Neysi; Waltz, Susan E; McHale, Mark; Welm, Alana L 2017. RON kinase: A target for treatment of cancer-induced bone destruction and osteoporosis. Science translational medicine, 9 374,

Hunt, Brian G; Wang, Yuan-Liang; Chen, Min-Shan; Wang, Shao-Chun; Waltz, Susan E 2017. Maternal diethylhexyl phthalate exposure affects adiposity and insulin tolerance in offspring in a PCNA-dependent manner. Environmental research, 159 , 588-594

Ruiz-Torres, Sasha J; Benight, Nancy M; Karns, Rebekah A; Lower, Elyse E; Guan, Jun-Lin; Waltz, Susan E 2017. HGFL-mediated RON signaling supports breast cancer stem cell phenotypes via activation of non-canonical β-catenin signaling. Oncotarget, 8 35, 58918-58933

Ruiz-Torres, Sasha J; Benight, Nancy M; Karns, Rebekah A; Lower, Elyse E; Guan, Jun-Lin; Waltz, Susan E 2017. HGFL-mediated RON signaling supports breast cancer stem cell phenotypes via activation of non-canonical ?-catenin signaling. Oncotarget, 8 35, 58918-58933

Zhou, Zilan; Jafari, Mina; Sriram, Vishnu; Kim, Jinsoo; Lee, Joo-Youp; Ruiz-Torres, Sasha J; Waltz, Susan E 2017. Delayed Sequential Co-Delivery of Gefitinib and Doxorubicin for Targeted Combination Chemotherapy. Molecular pharmaceutics, 14 12, 4551-4559

Zhou, Zilan; Kennell, Carly; Jafari, Mina; Lee, Joo-Youp; Ruiz-Torres, Sasha J; Waltz, Susan E; Lee, Jing-Huei 2017. Sequential Delivery of Erlotinib and Doxorubicin for Enhanced Triple Negative Breast Cancer Treatment Using Polymeric Nanoparticle. International journal of pharmaceutics, ,

2015

Benight, Nancy M; Wagh, Purnima K; Zinser, Glendon M; Peace, Belinda E; Stuart, William D; Vasiliauskas, Juozas; Pathrose, Peterson; Starnes, Sandra L; Waltz, Susan E 2015. HGFL supports mammary tumorigenesis by enhancing tumor cell intrinsic survival and influencing macrophage and T-cell responses. Oncotarget, 6 19, 17445-61

Johnson, Abby L; Zinser, Glendon M; Waltz, Susan E 2015. Vitamin D3-dependent VDR signaling delays ron-mediated breast tumorigenesis through suppression of Beta-catenin activity Oncotarget, 6 18, 16304-20

Stuart, William D; Brown, Nicholas E; Paluch, Andrew M; Waltz, Susan E 2015. Loss of Ron receptor signaling leads to reduced obesity, diabetic phenotypes and hepatic steatosis in response to high fat diet in mice. American journal of physiology. Endocrinology and metabolism, 308 7, E562-72